AAAAAA

   
Results: 1-11 |
Results: 11

Authors: GUYAUX M GOBERT J NOYER M VANDEVELDE M WULFERT E
Citation: M. Guyaux et al., MIVAZEROL PREVENTS THE TACHYCARDIA CAUSED BY EMERGENCE FROM HALOTHANEANESTHESIA PARTLY THROUGH ACTIVATION OF SPINAL ALPHA(2)-ADRENOCEPTORS, Acta anaesthesiologica Scandinavica, 42(2), 1998, pp. 238-245

Authors: FLAMEZ A GILLARD M DEBACKER JP VAUQUELIN G NOYER M
Citation: A. Flamez et al., THE NOVEL ALPHA(2)-ADRENOCEPTOR AGONIST [H-3] MIVAZEROL BINDS TO NONADRENERGIC BINDING-SITES IN HUMAN STRIATUM MEMBRANES THAT ARE DISTINCT FROM IMIDAZOLINE RECEPTORS, Neurochemistry international, 31(1), 1997, pp. 125-129

Authors: GUYAUX M GOBERT J NOYER M VANDEVELDE M WULFERT E
Citation: M. Guyaux et al., MIVAZEROL PREVENTS THE TACHYCARDIA CAUSED BY EMERGENCE FROM HALOTHANEANESTHESIA PARTLY THROUGH ACTIVATION OF SPINAL ALPHA(2) ADRENOCEPTORS, British Journal of Pharmacology, 122, 1997, pp. 114-114

Authors: RICHER C GOBERT J NOYER M WULFERT E GIUDICELLI JF
Citation: C. Richer et al., PERIPHERAL ALPHA(2)-ADRENOCEPTOR-MEDIATED SYMPATHOINHIBITORY EFFECTS OF MIVAZEROL, Fundamental and clinical pharmacology, 10(6), 1996, pp. 529-537

Authors: MOGUILEVSKY N VARSALONA F GUILLAUME JP NOYER M GILLARD M DALIERS J HENICHART JP BOLLEN A
Citation: N. Moguilevsky et al., PHARMACOLOGICAL AND FUNCTIONAL-CHARACTERIZATION OF THE WILD-TYPE AND SITE-DIRECTED MUTANTS OF THE HUMAN H-1 HISTAMINE-RECEPTOR STABLY EXPRESSED IN CHO CELLS, Journal of receptor and signal transduction research, 15(1-4), 1995, pp. 91-102

Authors: GOWER AJ HIRSCH E BOEHRER A NOYER M MARESCAUX C
Citation: Aj. Gower et al., EFFECTS OF LEVETIRACETAM, A NOVEL ANTIEPILEPTIC DRUG, ON CONVULSANT ACTIVITY IN 2 GENETIC RAT MODELS OF EPILEPSY, Epilepsy research, 22(3), 1995, pp. 207-213

Authors: NOYER M GILLARD M MATAGNE A HENICHART JP WULFERT E
Citation: M. Noyer et al., THE NOVEL ANTIEPILEPTIC DRUG LEVETIRACETAM (UCB L059) APPEARS TO ACT VIA A SPECIFIC BINDING-SITE IN CNS MEMBRANES, European journal of pharmacology, 286(2), 1995, pp. 137-146

Authors: GOWER AJ HIRSCH E BOEHRER A NOYER M MARESCAUX C
Citation: Aj. Gower et al., EFFECT OF LEVATIRACETAM IN A GENETIC MODEL OF ABSENCE EPILEPSY IN RATS, Epilepsia, 36, 1995, pp. 38-38

Authors: NOYER M DELAVELEYE F VAUQUELIN G GOBERT J WULFERT E
Citation: M. Noyer et al., MIVAZEROL, A NOVEL COMPOUND WITH HIGH SPECIFICITY FOR ALPHA(2)-ADRENERGIC RECEPTORS - BINDING-STUDIES ON DIFFERENT HUMAN AND RAT MEMBRANE PREPARATIONS, Neurochemistry international, 24(3), 1994, pp. 221-229

Authors: MOGUILEVSKY N VARSALONA F NOYER M GILLARD M GUILLAUME JP GARCIA L SZPIRER C BOLLEN A SZPIRER J
Citation: N. Moguilevsky et al., STABLE EXPRESSION OF HUMAN H-1-HISTAMINE-RECEPTOR CDNA IN CHINESE-HAMSTER OVARY CELLS - PHARMACOLOGICAL CHARACTERIZATION OF THE PROTEIN, TISSUE DISTRIBUTION OF MESSENGER-RNA AND CHROMOSOMAL LOCALIZATION OF THEGENE, European journal of biochemistry, 224(2), 1994, pp. 489-495

Authors: GILLARD M NOYER M HENICHART JP WULFERT E
Citation: M. Gillard et al., THE NOVEL ANTIEPILEPTIC DRUG LEVETIRACETAM (UCB L059) APPEARS TO ACT VIA A SPECIFIC BINDING-SITE IN CNS MEMBRANES, British Journal of Pharmacology, 112, 1994, pp. 210000095-210000095
Risultati: 1-11 |